A detailed history of Y Intercept (Hong Kong) LTD transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 12,404 shares of NAUT stock, worth $21,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,404
Previous 23,916 48.14%
Holding current value
$21,334
Previous $55,000 36.36%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$2.24 - $3.08 $25,786 - $35,456
-11,512 Reduced 48.14%
12,404 $35,000
Q2 2024

Aug 14, 2024

BUY
$2.22 - $3.0 $53,093 - $71,748
23,916 New
23,916 $55,000
Q2 2022

Aug 08, 2022

SELL
$2.64 - $4.84 $42,519 - $77,953
-16,106 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.5 - $5.3 $56,371 - $85,361
16,106 New
16,106 $70,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $214M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.